Literature DB >> 11710239

The development of the alpha-particle emitting radionuclides 212Bi and 213Bi, and their decay chain related radionuclides, for therapeutic applications.

S Hassfjell1, M W Brechbiel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11710239     DOI： 10.1021/cr000118y

Source DB:  PubMed          Journal:  Chem Rev        ISSN： 0009-2665            Impact factor:   60.622


× No keyword cloud information.
  25 in total

1.  In vitro evaluation of 213Bi-rituximab versus external gamma irradiation for the treatment of B-CLL patients: relative biological efficacy with respect to apoptosis induction and chromosomal damage.

Authors:  Katia Vandenbulcke; Filip De Vos; Fritz Offner; Jan Philippé; Christos Apostolidis; Roger Molinet; Tuomo K Nikula; Klaus Bacher; Virginie de Gelder; Anne Vral; Christophe Lahorte; Hubert Thierens; Rudi A Dierckx; Guido Slegers
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-07-03       Impact factor: 9.236

Review 2.  Targeted alpha-therapy: past, present, future?

Authors:  Martin W Brechbiel
Journal:  Dalton Trans       Date:  2007-09-11       Impact factor: 4.390

3.  Efficient bifunctional decadentate ligand 3p-C-DEPA for targeted α-radioimmunotherapy applications.

Authors:  Hyun A Song; Chi Soo Kang; Kwamena E Baidoo; Diane E Milenic; Yunwei Chen; Anzhi Dai; M W Brechbiel; Hyun-Soon Chong
Journal:  Bioconjug Chem       Date:  2011-05-23       Impact factor: 4.774

4.  Preclinical evaluation of NETA-based bifunctional ligand for radioimmunotherapy applications using 212Bi and 213Bi: radiolabeling, serum stability, and biodistribution and tumor uptake studies.

Authors:  Chi Soo Kang; Hyun A Song; Diane E Milenic; Kwamena E Baidoo; Martin W Brechbiel; Hyun-Soon Chong
Journal:  Nucl Med Biol       Date:  2013-03-27       Impact factor: 2.408

5.  Performance assessment of semiempirical molecular orbital methods in the structural prediction of Sb(III) and Bi(III) complexes.

Authors:  Evandro Paulo Soares Martins; Gerd B Rocha
Journal:  J Mol Model       Date:  2013-10       Impact factor: 1.810

Review 6.  Dithiocarbamate complexes as radiopharmaceuticals for medical imaging.

Authors:  David J Berry; Rafael Torres Martin de Rosales; Putthiporn Charoenphun; Philip J Blower
Journal:  Mini Rev Med Chem       Date:  2012-10       Impact factor: 3.862

7.  Novel bimodal bifunctional ligands for radioimmunotherapy and targeted MRI.

Authors:  Hyun-Soon Chong; Hyun A Song; Xiang Ma; Diane E Milenic; Erik D Brady; Sooyoun Lim; Haisung Lee; Kwamena Baidoo; Dengfeng Cheng; Martin W Brechbiel
Journal:  Bioconjug Chem       Date:  2008-06-20       Impact factor: 4.774

Review 8.  Peptide-targeted radionuclide therapy for melanoma.

Authors:  Yubin Miao; Thomas P Quinn
Journal:  Crit Rev Oncol Hematol       Date:  2008-04-02       Impact factor: 6.312

9.  Streptavidin in antibody pretargeting. 5. chemical modification of recombinant streptavidin for labeling with the alpha-particle-emitting radionuclides 213Bi and 211At.

Authors:  D Scott Wilbur; Donald K Hamlin; Ming-Kuan Chyan; Martin W Brechbiel
Journal:  Bioconjug Chem       Date:  2007-12-12       Impact factor: 4.774

10.  Rational design and generation of a bimodal bifunctional ligand for antibody-targeted radiation cancer therapy.

Authors:  Hyun-Soon Chong; Xiang Ma; Thien Le; Baidoo Kwamena; Diane E Milenic; Erik D Brady; Hyun A Song; Martin W Brechbiel
Journal:  J Med Chem       Date:  2007-12-07       Impact factor: 7.446
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.